Bloomios, Inc. financial data

Industry
Medicinal Chemicals & Botanical Products
Location
701 Anacapa Street, Suite C, Santa Barbara, CA
Fiscal year end
December 31
Former names
XLR MEDICAL CORP. (to 4/15/2021), RELAY MINES LTD (to 8/30/2004)
Latest financial report
10-Q - Q3 2023 - Nov 20, 2023

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 5.88 % -63.6%
Quick Ratio 4.27 % -24.1%
Debt-to-equity -290 % -30.1%
Return On Equity 381 % +127%
Return On Assets -200 % -46.7%
Operating Margin -61.8 % +1.84%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 64.5M shares +352%
Common Stock, Shares, Outstanding 61.5M shares +362%
Entity Public Float 4.3M USD +277%
Common Stock, Value, Issued 754 USD +301%
Weighted Average Number of Shares Outstanding, Basic 12.8M shares +2.65%
Weighted Average Number of Shares Outstanding, Diluted 13.2M shares -46.9%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 8.23M USD +46.5%
Operating Income (Loss) -5.08M USD -43.8%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -40.3M USD -691%
Income Tax Expense (Benefit) 0 USD
Net Income (Loss) Attributable to Parent -40.3M USD -691%
Earnings Per Share, Basic -0.1 USD/shares +23.1%
Earnings Per Share, Diluted -0.09 USD/shares -550%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 0 USD -100%
Inventory, Net 0 USD -100%
Assets, Current 346K USD -21.8%
Property, Plant and Equipment, Net 732K USD -67.4%
Goodwill 300K USD 0%
Assets 1.93M USD -40.5%
Accounts Payable, Current 3.52M USD +101%
Accrued Liabilities, Current 481K USD +76.4%
Liabilities, Current 33.1M USD +311%
Operating Lease, Liability, Noncurrent 99.5K USD
Liabilities 33.4M USD +307%
Retained Earnings (Accumulated Deficit) -51.2M USD -371%
Stockholders' Equity Attributable to Parent -31.5M USD -535%
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest -31.5M USD
Liabilities and Equity 1.93M USD -40.5%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -528K USD -62.3%
Net Cash Provided by (Used in) Financing Activities 528K USD +61.5%
Net Cash Provided by (Used in) Investing Activities 0 USD
Common Stock, Shares Authorized 950M shares 0%
Common Stock, Shares, Issued 61.5M shares +362%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 0 USD
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 0 USD -100%
Interest Paid, Excluding Capitalized Interest, Operating Activities 0 USD
Deferred Tax Assets, Valuation Allowance 5.28M USD
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent 0.21 pure
Deferred Tax Assets, Gross 5.28M USD +132%
Depreciation 243K USD -43.5%
Preferred Stock, Shares Authorized 5M shares 0%
Additional Paid in Capital 11.2M USD +89.6%
Deferred Tax Assets, Net of Valuation Allowance 0 USD
Interest Expense 2.8M USD +332%